These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6436937)

  • 21. Respiratory distress and surfactant inhibition following vagotomy in rabbits.
    Berry D; Ikegami M; Jobe A
    J Appl Physiol (1985); 1986 Nov; 61(5):1741-8. PubMed ID: 3781984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Stachybotrys chartarum (atra) conidia and isolated toxin on lung surfactant production and homeostasis.
    Mason CD; Rand TG; Oulton M; MacDonald JM; Scott JE
    Nat Toxins; 1998; 6(1):27-33. PubMed ID: 9851509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary transvascular fluid and protein exchange after thrombin-induced microembolism. Differential effects of cyclooxygenase inhibitors.
    Johnson A; Malik AB
    Am Rev Respir Dis; 1985 Jul; 132(1):70-6. PubMed ID: 3925828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism of exogenously administered surfactant in the acutely injured lungs of adult rabbits.
    Lewis JF; Ikegami M; Jobe AH
    Am Rev Respir Dis; 1992 Jan; 145(1):19-23. PubMed ID: 1731583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indomethacin, but not dazoxiben, reduced lung fluid filtration after E. coli infusion.
    Winn R; Enderson B; Price S; Rice CL
    J Appl Physiol (1985); 1988 Jun; 64(6):2468-73. PubMed ID: 3042734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. OKY-046 prevents increases in LTB4 and pulmonary edema in phorbol ester-induced lung injury in dogs.
    Sprague RS; Stephenson AH; Lonigro AJ
    J Appl Physiol (1985); 1992 Dec; 73(6):2493-8. PubMed ID: 1337076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody to surfactant protein A increases sensitivity of pulmonary surfactant to inactivation by fibrinogen in vivo.
    Strayer DS; Herting E; Sun B; Robertson B
    Am J Respir Crit Care Med; 1996 Mar; 153(3):1116-22. PubMed ID: 8630554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered surfactant synthesis and function in rats with diet-induced hyperlipidemia.
    Baritussio A; Enzi G; Inelmen EM; Schiavon M; de Biasi F; Allegra L; Ursini F; Baldo G
    Metabolism; 1980 Jun; 29(6):503-10. PubMed ID: 6892941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of indomethacin and PEEP on oleic acid induced pulmonary oedema in rabbits.
    Panaretto KS; Phillips C; Berend N
    Eur Respir J; 1991 Jul; 4(7):853-9. PubMed ID: 1955008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of lipoxygenase and cyclo-oxygenase inhibition on oleic acid-induced lung oedema.
    Angeli S; Bonnet A; Zabner J; Martinez-Ruiz R; Sánchez de León R
    Acta Physiol Pharmacol Ther Latinoam; 1992; 42(2):75-85. PubMed ID: 1300158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of dipalmitoyl lecithin by alveolar macrophages.
    Mason RJ; Huber G; Vaughan M
    J Clin Invest; 1972 Jan; 51(1):68-73. PubMed ID: 5066597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thromboxane A2 mediates augmented polymorphonuclear leukocyte adhesiveness.
    Spagnuolo PJ; Ellner JJ; Hassid A; Dunn MJ
    J Clin Invest; 1980 Sep; 66(3):406-14. PubMed ID: 6772674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the effects on inhibition of cyclooxygenase and thromboxane synthetase on renal excretion and haemodynamics in rats of different ages.
    Bartha J; Hably C; Herceg R; Bálint G; Bräunlich H
    Acta Physiol Hung; 1989; 73(1):29-37. PubMed ID: 2496580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thromboxane-mediated activation of platelets and enhancement of platelet uptake onto collagen-coated glass or deendothelialized rabbit aorta. Comparative effects of a thromboxane antagonist (EPO45) and a thromboxane synthetase inhibitor (dazoxiben).
    Menys VC; Davies JA
    Lab Invest; 1984 Feb; 50(2):184-9. PubMed ID: 6546403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of oxygen metabolites on rat alveolar type II cell viability and surfactant metabolism.
    Crim C; Simon RH
    Lab Invest; 1988 Apr; 58(4):428-37. PubMed ID: 2833658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thromboxane does not mediate pulmonary vascular response to monocrotaline pyrrole.
    Ganey PE; Roth RA
    Am J Physiol; 1987 Apr; 252(4 Pt 2):H743-8. PubMed ID: 2952022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of thromboxane A2 synthetase inhibitor, DP-1904 on the action of vasoactive substances in rabbit blood vessel smooth muscle preparations].
    Shimizu K; Kobayashi J; Iwanaga T; Kuratomi Y; Kitamura S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 May; 27(5):591-6. PubMed ID: 2615099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ontogeny of rat lung type II cells correlated with surfactant lipid and surfactant apoprotein expression.
    Randell SH; Silbajoris R; Young SL
    Am J Physiol; 1991 Jun; 260(6 Pt 1):L562-70. PubMed ID: 2058697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adrenalectomy and surfactant in adult rats.
    Liebowitz D; Massaro GD; Massaro D
    J Appl Physiol Respir Environ Exerc Physiol; 1984 Mar; 56(3):564-7. PubMed ID: 6546744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of cyclooxygenase and thromboxane synthetase inhibitors upon amphetamine and caffeine action at the level of central nervous system (CNS).
    Dumitrescu S; Nechifor M
    Rev Med Chir Soc Med Nat Iasi; 1982; 86(3):505-6. PubMed ID: 6820543
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.